Lindbrook Capital’s Denali Therapeutics DNLI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | $2.08K | Sell |
153
-102
| -40% | -$1.39K | ﹤0.01% | 2275 |
|
|
2024
Q4 | $5.2K | Sell |
255
-28
| -10% | -$571 | ﹤0.01% | 1971 |
|
|
2024
Q3 | $8.24K | Buy |
283
+58
| +26% | +$1.69K | ﹤0.01% | 1783 |
|
|
2024
Q2 | $5.23K | Sell |
225
-89
| -28% | -$2.07K | ﹤0.01% | 1970 |
|
|
2024
Q1 | $6.44K | Sell |
314
-332
| -51% | -$6.81K | ﹤0.01% | 1787 |
|
|
2023
Q4 | $13.9K | Buy |
646
+407
| +170% | +$8.73K | ﹤0.01% | 1366 |
|
|
2023
Q3 | $4.93K | Sell |
239
-403
| -63% | -$8.32K | ﹤0.01% | 1778 |
|
|
2023
Q2 | $18.9K | Buy |
642
+188
| +41% | +$5.55K | ﹤0.01% | 1124 |
|
|
2023
Q1 | $10.5K | Buy |
454
+99
| +28% | +$2.28K | ﹤0.01% | 1427 |
|
|
2022
Q4 | $9.87K | Buy |
355
+78
| +28% | +$2.17K | ﹤0.01% | 1436 |
|
|
2022
Q3 | $9K | Buy |
277
+54
| +24% | +$1.76K | ﹤0.01% | 1363 |
|
|
2022
Q2 | $7K | Buy |
223
+19
| +9% | +$596 | ﹤0.01% | 1396 |
|
|
2022
Q1 | $7K | Sell |
204
-407
| -67% | -$14K | ﹤0.01% | 1438 |
|
|
2021
Q4 | $27K | Buy |
+611
| New | +$27K | ﹤0.01% | 914 |
|
|
2021
Q2 | – | Sell |
-34
| Closed | -$2K | – | 1930 |
|
|
2021
Q1 | $2K | Buy |
+34
| New | +$2K | ﹤0.01% | 1530 |
|